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PURPOSE. We study the relationship between retinal vessel oxygenation and the spatial
distribution of retinal nonperfusion using ultrawide field angiography in eyes with retinal
vascular diseases.
METHODS. This prospective single center study recruited 57 eligible eyes from 44 patients with
retinal vascular diseases. Retinal oximetry measurements were obtained using the Oxymap T1
device to determine the arteriovenous (AV) difference. Retinal nonperfusion was measured
from ultrawide field angiography images taken with the Optos 200TX system and
superimposing the images with the concentric rings template to determine the area and
distribution of retinal nonperfusion.
RESULTS. Seven (12.3%) eyes had a diagnosis of a branch or hemiretinal vein occlusion, 24
(42.1%) with central retinal vein occlusion and 26 (45.6%) with diabetic retinopathy (11
[19.3%] nonproliferative and 15 [26.3%] proliferative diabetic retinopathy). The correlation
between the total area of retinal nonperfusion with the AV difference controlling for age was
not statistically significant (R ¼ 0.103, P ¼ 0.449). However, when analyzing the
correlation of AV difference with the area of retinal nonperfusion in the posterior pole
controlling for age and peripheral nonperfusion, this was significant (R ¼ 0.295, P ¼
0.029). This was not significant for the area of retinal nonperfusion in the periphery while
controlling for posterior pole nonperfusion and age (R ¼ 0.124, P ¼ 0.368).
CONCLUSIONS. Retinal nonperfusion has a negative correlation with AV difference measured on
retinal oximetry. This correlation is significant in the posterior pole, but not in the peripheral
retina.
Keywords: oxygenation, oximetry, retinal nonperfusion, diabetic retinopathy, retinal vein
occlusion
The public health burden of visual impairment due to retinalvascular diseases is significant. The most common retinal
vascular diseases are diabetic retinopathy and retinal vein
occlusion. The majority of sight-threatening complications of
retinal vascular diseases are the sequelae of retinal capillary
nonperfusion.
The retina is unique in its oxygenation because retinal
vessels must provide and extract oxygen without structurally
obscuring the visual axis. This requires efficient oxygen
delivery given the limited vasculature permitted. Retinal
nonperfusion in retinal vascular diseases can result in ischemia.
The retina has the highest oxygen consumption of any tissue of
the body and most oxygen is consumed by the retinal
photoreceptors.1,2 The photoreceptor has limited mitochon-
drial reserve capacity increasing its vulnerability to metabolic
changes.3 In the diseased state, because of the retina’s unique
demand for oxygen, even subtle decreases in oxygen availabil-
ity can result in a hypoxic state.1,4
Studies on retinal oxygenation are essential in further
understanding the relationship of retinal oxygenation and
ischemia in retinal vascular disorders. Early retinal oxygenation
studies involved invasive tests and were restricted to studies in
animal models. Human studies require noninvasive methods to
evaluate retinal oxygenation. A recent method for measuring
retinal vessel oxygenation has been developed by Hardarson et
al.5 in Reykjavic, Iceland. It is composed of a fundus camera and
beam splitter. A software (Oxymap analyzer) then is used to
analyze the data obtained. The validity of retinal oximetry
measurements has been studied with reports of excellent
reliability and reproducibility.6,7
Current literature on the use of oximetry in retinal diseases
is expanding. Several studies have evaluated retinal vessel
oxygenation in retinal vein occlusion, diabetic retinopathy,
retinitis pigmentosa, and neovascular age-related macular
degeneration.8–11 Early studies evaluated retinal oximetry
measurements in different retinal vascular diseases and revealed
varying results.8,12–14 The concept of arteriovenous difference
then was used to reveal oxygen consumption and several
studies evaluated this parameter in varying severity of diabetic
retinopathy with inconsistent results, but a general trend
toward reduction in AV difference with increasing severity of
diabetic retinopathy.15–17 A similar finding is observed in retinal
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vein occlusion.18–20 The variability in area of retinal non-
perfusion is evident in these retinal vascular diseases and, thus,
more recent studies have focused on the relationship of retinal
nonperfusion in these conditions with the AV difference with
more promising results.15,21 However, these studies were done
on small sample sizes; the largest subgroup was 17 for diabetic
retinopathy and 23 for retinal vein occlusion, and again with
varying results. Secondly, the metabolic demand is not equally
distributed within the retina and, therefore, the location of
ischemia will likely have an effect on oxygen consumption.22
Finally, age may be a confounding variable as well and
controlling for this variable was scarcely performed in these
previous studies.
We prospectively assessed the correlation between the
spatial location of retinal nonperfusion measured using the
validated concentric rings method with the AV difference as
measured on retinal oximetry in a sufficiently powered study.
METHODS
This prospective cross-sectional study was done from Decem-
ber 30, 2014 to August 24, 2016 at the National Institute for
Health Research Moorfields Biomedical Research Centre and
the Institute of Ophthalmology, University College London,
United Kingdom. The study was granted approval by the Wales
Research Ethics Committee 6 (14/WA/1224). The study was
implemented in accordance with Good Clinical Practice and
the Declaration of Helsinki.
Inclusion and Exclusion Criteria
Eligible patients 18 years or older with a diagnosis of any
retinal vascular diseases who had the capacity to provide
informed consent were included. Sufficient media clarity and
pupillary dilatation for adequate fundus photographs were
required. Participants must have undergone fluorescein
angiography using the Optos ultrawide field system (Optos,
Dunfermline, Scotland) within 6 months or were due to
undergo one in a month. Patients with poor quality images on
angiography or retinal oximetry were excluded. Previous
retinal laser treatment and other retinal diseases also were
excluded.
Investigative Procedures
Oximetry. Retinal oximetry was performed using the
retinal oximeter (Oxymap T1 device connected to Topcon
TRC50-DX fundus camera; Oxymap ehf., Reykjavik, Iceland). It
consisted of a fundus camera with an attached beam splitter as
well as a digital camera. The Oxymap T1 acquires two images
at two different wavelengths of the same area (586 nm, which
is insensitive to oxygen, and 605 nm, which is oxygen-
sensitive). The ratio of these optical densities (absorbance) is
approximately linearly related to hemoglobin oxygen satura-
tion12,23,24 The oximeter is calibrated to yield relative oxygen
saturation values.5 The two spectral images are processed by
the Oxymap analyzer software to give predicted oxygen
saturation values.
Optic disc centered images were captured through dilated
pupils and the images were 12003 1600 pixels and covered a
508 field of central retina. The images were captured for both
eyes, but only the affected eye(s) was used in this analysis.
Images were analyzed using the Oxymap Analyzer software
(Oxymap ehf.). A minimum vessel width of eight pixels was set
and vessels less than eight pixels were automatically excluded
from the analysis. Oximetry measurements were performed
using previously reported methods whereby the intragrader
intraclass correlation coefficient was reported to be 0.89 to
0.99.25 In brief, an initial central circle was used to delineate
the optic disc. Two additional measurement circles are made,
one three times and the following circle 1.5 times the diameter
of the central circle. The area between these two additional
circles centered on the optic disc was analyzed. Areas where
vessel detection would prove inaccurate (branching, overlap-
ping, background hemorrhage, or intersecting), and segments
of vessels less than 50 pixels long were excluded. Vessels to be
measured were selected manually. The retinal oximetry data
streams were extracted from the source data file. Data
collected from the Oxymap software included mean arteriolar
oxygen saturations (SaO2), mean venular oxygen saturations
(SvO2), and mean arterial vessel, and mean venular diameter.
The difference in arterial and venular oxygenation was
determined and referred to as the AV difference.
Fluorescein Angiography. The ultrawide field angiogra-
phy images were obtained using the Optos 200TX ultrawide
field system observing a standard protocol after an intravenous
bolus infusion of 5 mL 20% fluorescein sodium. The protocol
consisted of acquiring images in transit phase, arteriovenous
phases, and late frames. A single investigator (LN) identified
the best macula centered fluorescein angiography (FA) image
in the arteriovenous phase from the FA series of each eligible
eye.
Image Processing
A correction factor was automatically applied for flattening of
the three-dimensional (3D) image to a two-dimensional image
via the Optos V2 Vantage Pro software. The concentric rings
template then was added to each image according to
previously described methods.26 This validated method incor-
porates a macular ring with a radius of 2.5 disc diameters (DD)
and five additional concentric rings (rings 1–5), each with a 2.5
DD increment in radius. Each of the six rings (Rings M and 1–5)
was divided into 12 segments. Each segment was graded as
upgradeable, not perfused, or perfused if 50% or more of the
segment was involved. In addition to quantifying nonperfu-
sion, the concentric rings method allowed documentation of
location of nonperfusion. The area of each cell in each
concentric ring was modified based on the enlargement factor
identified using 3D printed model eyes. The modified area of
each segment based on the corresponding enlargement factor
in each ring was used.27,28 The montaged image, using a
steering protocol to obtain three images (superior, central,
inferior), introduced projection distortions that as yet had not
been studied or validated as the location of the same area of the
retina is distorted differently in different images given the
different angular location. Therefore, only the central image
was used in this study as the projection distortion in this has
been studied previously and we have made the appropriate
corrections.
Image Analysis
Two graders who are retinal specialists (LN and CVA) measured
the area of retinal nonperfusion using the concentric rings
method on a Samsung LED 46-inch 1080p television screen.
The area measured was averaged between the two graders. The
average values for each ring (Rings M, and 1–4) were
determined. Ring 5 was excluded from the analysis due to
the high number of ungradable segments reported previously.
A single investigator (LN) reviewed ultrawide field autofluo-
rescence images taken with the Optos 200TX system of eyes in
the cohort where available to assess for loss of autofluores-
cence which may be suggestive of photoreceptor loss.
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Statistical Analysis
The sample size was calculated based on the primary objective.
To our knowledge, no previous studies exist comparing this
specifically at the start of the study. Observing previous reports
on oximetry readings in retinal vein occlusion and proliferative
diabetic retinopathy, a medium effect size was expected.8,21,29
Therefore, with a probability level of 5% and to achieve 80%
power for correlation analysis, a sample size of 54 was
required. The association between AV difference and area of
retinal nonperfusion was measured using a partial correlation
controlling for age. The association between posterior non-
perfusion and AV difference was controlled for age and
peripheral nonperfusion, and the associated between periph-
eral nonperfusion and AV difference was controlled for age and
posterior nonperfusion. Analysis was performed using SPSS
version 22.0 (IBM Corp., Armonk, New York, USA).
RESULTS
A total of 57 eyes from 44 patients (mean age, 58.2 6 20.2
years; range, 25–94) fulfilled the eligibility criteria and were
analyzed. Seven (12.3%) eyes had branch or hemiretinal vein
occlusion, 24 (42.1%) central retinal vein occlusion, and 26
(45.6%) diabetic retinopathy (11 [19.3%] nonproliferative and
15 [26.3%] proliferative).
Mean area of retinal nonperfusion in the whole cohort
measured 98.7 6 77.4 DA. Mean arterial oxygen saturations
were 95.64% 6 8.37% and venular saturations were 51.19% 6
13.13%. Mean AV difference calculated was 44.46% 6 14.65%.
The correlation between the total area of retinal nonperfusion
with AV difference controlling for age was not statistically
significant (R ¼0.103, P ¼ 0.449). However, when analyzing
the correlation of AV difference with the area of retinal
nonperfusion in the posterior pole (Rings M and 1) while
controlling for age and peripheral nonperfusion, the correla-
tion was significant (R ¼0.295, P ¼ 0.029). The correlation
was not significant for the AV difference and peripheral
nonperfusion while controlling for age and posterior non-
perfusion (R ¼ 0.124, P ¼ 0.368).
The arteriolar and venular saturations and AV difference for
branch or hemiretinal vein occlusions, central retinal vein
occlusions, and nonproliferative and proliferative diabetic
retinopathy are presented in the Figure. The correlation
between AV difference and area of retinal nonperfusion for
the total cohort and individual diseases also are presented in
the Table. All 32 eyes that had autofluorescence imaging (32/
32) had no abnormal loss of autofluorescence.
DISCUSSION
In this prospective study, we found a negative correlation
between the AV difference in oxygen saturations and the area
of retinal nonperfusion in eyes with retinal vascular diseases.
Globally, statistical significance was not achieved, but when
studied within regions, the AV difference was correlated
significantly with area of nonperfusion in the posterior pole.
The association was not significant for the periphery. This
finding can be explained by the original hypothesis that the
larger the area of retinal nonperfusion, the lesser the amount of
viable retinal tissue and so the oxygen consumption is reduced.
This reduced use leads to reduce oxygen extraction and a
reduced AV difference. Interestingly, this association is
significant only in the posterior retina and not in the periphery.
This may explain the varied results seen in previous reports
and, to an extent, the global effect of retinal nonperfusion with
AV difference in our cohort. This negative correlation between
AV difference and posterior nonperfusion corroborates previ-
ous findings of the significance of posterior nonperfusion in
retinal diseases, such as central retinal vein occlusion.28 The
importance of posterior ischemia and the metabolic demands
of the retina has not been described as the noninvasive
FIGURE. The arteriolar and venular oxygen saturations and AV differences in oxygen saturations in retinal vascular diseases.
TABLE. The Correlation of Area of Retinal Nonperfusion With AV
Differences in Retinal Vascular Diseases While Controlling for Age
Disease
Category
Number
of
Eyes
Mean Area
of Retinal
Nonperfusion, DA R P Value
All eyes 57 98.7 6 77.4 0.103 0.449
Retinal vein
occlusion
31 58.7 6 52.2 0.149 0.433
Diabetic
retinopathy
26 124.3 6 58.9 0.053 0.801
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assessment of metabolic demands of the retina was not easily
tested previously. With retinal oximetry, we have now
identified a relationship between these variables. The results
suggested the significant oxygen demands of the posterior pole
and nonperfusion in this region results in reduced oxygen
extraction from the retinal circulation. This may be a
contributory factor for the development of neovascularization
which has been shown to be related to posterior pole
nonperfusion and oximetry measurements of new vessels that
have near arterial oxygen saturation levels.28,30,31 In a clinical
setting, using the AV difference measured with a noninvasive
tool can aid the clinician in identifying an ischemic or
nonischemic retina should angiography not be possible or
available.
The retinal thickness decreases significantly toward the
periphery.32 The oxygen distribution curve has been reported
to have two peaks with increased oxygen tension in the inner
retina mainly at the superficial retina, which then decreases to
a minimum at approximately 150 lm depth and increases
toward the Bruch’s membrane, depth 400 to 450 lm, in animal
models.1,33 Toward the periphery, the vascular density also is
reduced from 10.1% at the macula to 1.3% at the far
periphery.34 The oxygen distribution curve of an induced
artery occlusion and in an avascular retina in animal models are
similar with reduced inner retinal oxygenation and peak levels
toward Bruch’s membrane.1 The oxygen demand of the inner
retina toward the peripheral retina is likely to be much less
compared to the posterior pole. Therefore, the significance of
the relation of posterior pole nonperfusion and the AV
difference in our study may be explained by the higher retinal
volume in the posterior pole having a larger effect on retinal
oxygenation as opposed to the periphery. The clinical
manifestations of posterior pole nonperfusion also have been
reviewed in its significance in neovascularization in central
retinal vein occlusion.28
The significant association with nonperfusion in the
posterior pole and poorer correlation with the periphery also
interestingly mirrors the photoreceptor density map.22,35 The
concentric rings template, when superimposed onto a rod
photoreceptor density map, reveals that rings M and 1 also
correspond to the zones of the retina with the highest rod
photoreceptor density.22 It is well established that retinal
photoreceptors are highly metabolically active cells.1 The rod
photoreceptors also are known to have a higher oxygen
demand.36,37 Therefore, the observation that the posterior pole
(Rings M and 1) corresponds to the zones with highest rod
photoreceptor density could be related to the high oxygen
consumption of the rod photoreceptor in the retina. However,
we acknowledge that in this study, OCT imaging over the
peripheral retina was not performed to ascertain the presence
of the ellipsoid layer over the mid-peripheral and peripheral
retina. Instead, we assessed the ultrawide field autofluores-
cence image where available to ensure no loss of autofluores-
cence suggesting loss of photoreceptor function was present.
The strengths of this study lies in the prospective nature of
the data collection, area of retinal nonperfusion that is
corrected for projection artefacts, measurement of area of
nonperfusion and retinal vessel oxygenation using a validated
method, and analysis that is controlled for age. Furthermore, to
our knowledge, no report has been published studying the
significance of the regional effects of nonperfusion on retinal
oxygenation. Also to our knowledge, this is the largest single
cohort series assessing the correlation between retinal non-
perfusion with AV difference. We acknowledge several
limitations, such as the fact that we included diabetic
retinopathy and retinal vein occlusion in our cohort. However,
the study specifically evaluated retinal nonperfusion from a
cross-sectional approach. The Oxymap system also had its
limitation in only being able to assess the global retinal
oxygenation by measuring the retinal vessels in the peripap-
illary area. Therefore, regional oximetry measurement is not
possible or have been validated using the current system.
Furthermore, previous validation studies were performed
mainly in healthy eyes.25,38 Therefore, retinal oximetry
measurement in eyes with severe retinal vascular diseases
despite multiple previous publications has not specifically
been validated.
In conclusion, retinal nonperfusion has a negative correla-
tion with AV difference measured on retinal oximetry. This
correlation is significant in the posterior pole, but not in the
peripheral retina.
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